Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT ID: NCT00274547
Last Updated: 2013-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1829 participants
INTERVENTIONAL
2001-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tiotropium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boehringer Ingelheim Study Coordinator
Role: STUDY_CHAIR
Boehringer Ingelheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
Carl T. Hayden VA Medical Center
Phoenix, Arizona, United States
Southern Arizona VA Health Care System
Tuscon, Arizona, United States
VA Long Beach Healthcare System
Long Beach, California, United States
Boehringer Ingelheim Investigational Site
Palo Alto, California, United States
Respiratory Diseases (111A)
Bay Pines, Florida, United States
J. Hillis Miller Health Center
Gainesville, Florida, United States
Veteran Affairs Medical Center
Hines, Illinois, United States
Veterans Affairs Medical Center
North Chicago, Illinois, United States
Boehringer Ingelheim Investigational Site
Indianapolis, Indiana, United States
Boehringer Ingelheim Investigational Site
Lexington, Kentucky, United States
4720 I-10 Service Road
Metairie, Louisiana, United States
Boehringer Ingelheim Investigational Site
Boston, Massachusetts, United States
Veteran Affairs Medical Center
Minneapolis, Minnesota, United States
Boehringer Ingelheim Investigational Site
Kansas City, Missouri, United States
Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
Boehringer Ingelheim Investigational Site
Reno, Nevada, United States
Boehringer Ingelheim Investigational Site
Buffalo, New York, United States
Bronx VA Medical Center
New York, New York, United States
Boehringer Ingelheim Investigational Site
Durham, North Carolina, United States
Dallas VAMC
Dallas, Texas, United States
Veterans Affairs Medical Center
Houston, Texas, United States
Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
Boehringer Ingelheim Investigational Site
Salt Lake City, Utah, United States
Hampton VA Medical Center
Hampton, Virginia, United States
Hunter Holmes McGuire Medical Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
205.266
Identifier Type: -
Identifier Source: org_study_id